Sort by
Items per page

Send to

Choose Destination

Best matches for galectin-3 AND liver OR galectin-3 AND hepatocellular:

Search results

Items: 1 to 20 of 41


Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.

Shirabe K, Bekki Y, Gantumur D, Araki K, Ishii N, Kuno A, Narimatsu H, Mizokami M.

J Gastroenterol. 2018 Jul;53(7):819-826. doi: 10.1007/s00535-017-1425-z. Epub 2018 Jan 9. Review.


Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS).

Kim H, Yu SJ, Yeo I, Cho YY, Lee DH, Cho Y, Cho EJ, Lee JH, Kim YJ, Lee S, Jun J, Park T, Yoon JH, Kim Y.

Mol Cell Proteomics. 2017 Jul;16(7):1312-1323. doi: 10.1074/mcp.M116.066704. Epub 2017 May 26.


Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinoma.

Li X, Chen Q, Yin D, Shi S, Yu L, Zhou S, Chen E, Zhou Z, Shi Y, Fan J, Zhou J, Dai Z.

Oncol Rep. 2017 Jun;37(6):3313-3320. doi: 10.3892/or.2017.5616. Epub 2017 May 2.


Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells.

Tummala KS, Brandt M, Teijeiro A, Graña O, Schwabe RF, Perna C, Djouder N.

Cell Rep. 2017 Apr 18;19(3):584-600. doi: 10.1016/j.celrep.2017.03.059.


The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.

Cao Z, Sun B, Zhao X, Zhang Y, Gu Q, Liang X, Dong X, Zhao N.

Int J Mol Sci. 2017 Feb 27;18(3). pii: E500. doi: 10.3390/ijms18030500.


Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis.

Liu T, Liu D, Liu R, Jiang H, Yan G, Li W, Sun L, Zhang S, Liu Y, Guo K.

Sci Rep. 2017 Jan 12;7:38918. doi: 10.1038/srep38918.


Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.

Pejnovic N, Jeftic I, Jovicic N, Arsenijevic N, Lukic ML.

World J Gastroenterol. 2016 Nov 28;22(44):9706-9717. Review.


M1-/M2-macrophage polarization in pseudolobules consisting of adipohilin-rich hepatocytes in thioacetamide (TAA)-induced rat hepatic cirrhosis.

Wijesundera KK, Izawa T, Tennakoon AH, Golbar HM, Tanaka M, Kuwamura M, Yamate J.

Exp Mol Pathol. 2016 Aug;101(1):133-42. doi: 10.1016/j.yexmp.2016.07.005. Epub 2016 Jul 21.


Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype.

Matter MS, Marquardt JU, Andersen JB, Quintavalle C, Korokhov N, Stauffer JK, Kaji K, Decaens T, Quagliata L, Elloumi F, Hoang T, Molinolo A, Conner EA, Weber A, Heikenwalder M, Factor VM, Thorgeirsson SS.

Hepatology. 2016 Jun;63(6):1888-99. doi: 10.1002/hep.28487. Epub 2016 Mar 15.


[Change in Serum Levels of New Hepatic Fibrosis Marker "Mac-2 Binding Protein Glycosylation isomer (M2BPGi)" in Patients with Chronic Hepatitis C during the Treatment of Pegylated Interferon and Ribavirin].

Ishida H, Suetsugu A, Nakamura M, Tauchi R, Nakayama J, Katano Y, Shirakami Y, Furuta N, Ito H, Seishima M.

Rinsho Byori. 2015 Aug;63(8):901-6. Japanese.


Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation.

Serizawa N, Tian J, Fukada H, Baghy K, Scott F, Chen X, Kiss Z, Olson K, Hsu D, Liu FT, Török NJ, Zhao B, Jiang JX.

Lab Invest. 2015 Oct;95(10):1145-56. doi: 10.1038/labinvest.2015.77. Epub 2015 Jul 6.


Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.

Jeftic I, Jovicic N, Pantic J, Arsenijevic N, Lukic ML, Pejnovic N.

Mol Med. 2015 May 22;21:453-65. doi: 10.2119/molmed.2014.00178.


Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.

Ulu M, Alacacioglu A, Yuksel E, Pamukk BO, Bozkaya G, Ari A, Yuksel A, Sop G, Alacacioglu I.

Saudi J Gastroenterol. 2015 Jan-Feb;21(1):47-50. doi: 10.4103/1319-3767.151228.


CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression.

Lin L, Han MM, Wang F, Xu LL, Yu HX, Yang PY.

Cell Death Dis. 2014 Oct 23;5:e1488. doi: 10.1038/cddis.2014.392.


Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma.

Jiang SS, Weng DS, Wang QJ, Pan K, Zhang YJ, Li YQ, Li JJ, Zhao JJ, He J, Lv L, Pan QZ, Xia JC.

J Transl Med. 2014 Sep 27;12:273. doi: 10.1186/s12967-014-0273-3.


A new human 3D-liver model unravels the role of galectins in liver infection by the parasite Entamoeba histolytica.

Petropolis DB, Faust DM, Deep Jhingan G, Guillen N.

PLoS Pathog. 2014 Sep 11;10(9):e1004381. doi: 10.1371/journal.ppat.1004381. eCollection 2014 Sep.


Insights into EPR effect versus lectin-mediated targeted delivery: biodegradable polycarbonate micellar nanoparticles with and without galactose surface decoration.

Ebrahim Attia AB, Oh P, Yang C, Tan JP, Rao N, Hedrick JL, Yang YY, Ge R.

Small. 2014 Nov 12;10(21):4281-6. doi: 10.1002/smll.201401295. Epub 2014 Aug 4.


Galectin-3 regulates hepatic progenitor cell expansion during liver injury.

Hsieh WC, Mackinnon AC, Lu WY, Jung J, Boulter L, Henderson NC, Simpson KJ, Schotanus B, Wojtacha D, Bird TG, Medine CN, Hay DC, Sethi T, Iredale JP, Forbes SJ.

Gut. 2015 Feb;64(2):312-21. doi: 10.1136/gutjnl-2013-306290. Epub 2014 May 16.


Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.

Zheng D, Hu Z, He F, Gao C, Xu L, Zou H, Wu Z, Jiang X, Wang J.

Oncol Rep. 2014 Jul;32(1):411-8. doi: 10.3892/or.2014.3170. Epub 2014 May 8.


Supplemental Content

Loading ...
Support Center